Literature DB >> 24333047

Review: maternal and placental antioxidant response to preeclampsia - impact on vasoactive eicosanoids.

J-F Bilodeau1.   

Abstract

The abnormally developed placenta is believed to be the pathophysiological cause of preeclampsia (PE). The resulting malperfusion of the placenta in PE can be associated with fluctuations in oxygen levels, leading to oxidative stress. How then do the placenta and the circulatory system of the mother adapt and respond to the increased oxidative challenge associated with PE? Many antioxidant systems have been shown to be upregulated or downregulated in the placenta and/or the maternal circulation during PE. Such altered antioxidant response can lead to increased lipid peroxidation. Oxidation of arachidonoyl residues in phospholipids generates bioactive lipids such as F2-isoprostanes, which are known vasoconstrictors. The consequences of changes in antioxidant status can also affect signal transduction and enzymatic pathways related to eicosanoid synthesis.
Copyright © 2013 IFPA and Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Catalase; Coenzyme Q(10); Eicosanoids; Glutathione; Glutathione peroxidase; Isoprostanes; Prostacyclin; Superoxide dismutase; Thromboxane; Vitamins

Mesh:

Substances:

Year:  2013        PMID: 24333047     DOI: 10.1016/j.placenta.2013.11.013

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  15 in total

1.  Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin.

Authors:  Scott W Walsh; Daniel T Reep; S M Khorshed Alam; Sonya L Washington; Marwah Al Dulaimi; Stephanie M Lee; Edward H Springel; Jerome F Strauss; Daniel J Stephenson; Charles E Chalfant
Journal:  Reprod Sci       Date:  2020-06-17       Impact factor: 3.060

2.  Relationship Between Xanthine Oxidase, Ischemia Modified Albumin, Nitric Oxide with Antioxidants in Non Pregnants, Pre and Post-delivery of Normal Pregnants and Preeclampsia.

Authors:  Vanishree Bambrana; C D Dayanand; Pushpa Kotur
Journal:  Indian J Clin Biochem       Date:  2016-08-03

3.  Plasma F2-isoprostane class VI isomers at 12-18 weeks of pregnancy are associated with later occurrence of preeclampsia.

Authors:  Jean-François Bilodeau; Shu Qin Wei; Jessica Larose; Karine Greffard; Vanessa Moisan; Francois Audibert; William D Fraser; Pierre Julien
Journal:  Free Radic Biol Med       Date:  2015-05-19       Impact factor: 7.376

4.  A High-Throughput Toxicity Screen of 42 Per- and Polyfluoroalkyl Substances (PFAS) and Functional Assessment of Migration and Gene Expression in Human Placental Trophoblast Cells.

Authors:  Bevin E Blake; Brittany P Rickard; Suzanne E Fenton
Journal:  Front Toxicol       Date:  2022-04-25

Review 5.  The prion protein family: a view from the placenta.

Authors:  Samira Makzhami; Bruno Passet; Sophie Halliez; Johan Castille; Katayoun Moazami-Goudarzi; Amandine Duchesne; Marthe Vilotte; Hubert Laude; Sophie Mouillet-Richard; Vincent Béringue; Daniel Vaiman; Jean-Luc Vilotte
Journal:  Front Cell Dev Biol       Date:  2014-08-08

Review 6.  Endothelial dysfunction and preeclampsia: role of oxidative stress.

Authors:  Lissette C Sánchez-Aranguren; Carlos E Prada; Carlos E Riaño-Medina; Marcos Lopez
Journal:  Front Physiol       Date:  2014-10-10       Impact factor: 4.566

7.  Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia.

Authors:  Cathal McCarthy; Louise C Kenny
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

Review 8.  A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.

Authors:  Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Michele Giannattasio; Gina Gregorini; Franca Giacchino; Rossella Attini; Valentina Loi; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2016-03-17       Impact factor: 3.902

Review 9.  The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta.

Authors:  Scott W Walsh; Jerome F Strauss
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

Review 10.  Oxidative Stress in Preeclampsia and Placental Diseases.

Authors:  Rajaa Aouache; Louise Biquard; Daniel Vaiman; Francisco Miralles
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.